Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
about
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesPhenotypic and Functional Properties of Human Steady State CD14+ and CD1a+ Antigen Presenting Cells and Epidermal Langerhans CellsFasciola hepatica glycoconjugates immuneregulate dendritic cells through the Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin inducing T cell anergy.The comings and goings of MHC class I molecules herald a new dawn in cross-presentation.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesLangerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells.Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.C-Type Lectin Receptors in Antiviral Immunity and Viral Escape.
P2860
Q26752558-3CC63C1C-8D18-41BD-BA4E-78F9E7666F58Q35852261-6F82DCF6-52FF-4ADB-BB2F-549D37A8BBEDQ38823551-0B25DF07-A2DE-4B88-B29E-CB5CD3EC2D6CQ38869721-E9F15AB7-6520-4C1B-A5FF-6B025C0DE65EQ39448911-0D58B5BC-2D5F-4560-AC1B-E9B7DC095065Q40443196-774F7241-F210-426E-8676-9DA626172345Q55378528-CCD8C586-A356-47C4-AE7C-57D305539B05Q55444816-A753F089-ADB5-4731-AEE5-E349538E9002
P2860
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cross-presentation through lan ...... s of glycan-modified antigens.
@en
type
label
Cross-presentation through lan ...... s of glycan-modified antigens.
@en
prefLabel
Cross-presentation through lan ...... s of glycan-modified antigens.
@en
P2093
P1476
Cross-presentation through lan ...... s of glycan-modified antigens.
@en
P2093
Cynthia M Fehres
Gert Storm
Hakan Kalay
Juan J Garcia-Vallejo
Louis van Bloois
Martino Ambrosini
Sandra J van Vliet
Sara A M Musaafir
Sven C M Bruijns
P356
10.1016/J.JCONREL.2015.01.040
P407
P577
2015-02-02T00:00:00Z